Halozyme Therapeutics
HALO
#2169
Rank
โ‚น624.39 B
Marketcap
โ‚น4,908
Share price
0.39%
Change (1 day)
74.57%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.84

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น150.77. In 2022 the company made an earnings per share (EPS) of โ‚น128.24 a decrease over its 2021 EPS that were of โ‚น246.94.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8411.39%
2022โ‚น128.24-48.07%
2021โ‚น246.94196.88%
2020โ‚น83.18-292%
2019-โ‚น43.32-9.09%
2018-โ‚น47.66-237.5%
2017โ‚น34.66-149.38%
2016-โ‚น70.18211.54%
2015-โ‚น22.53-52.73%
2014-โ‚น47.66-24.66%
2013-โ‚น63.2548.98%
2012-โ‚น42.46145%
2011-โ‚น17.33-64.29%
2010-โ‚น48.52-17.65%
2009-โ‚น58.929.68%
2008-โ‚น53.7293.75%
2007-โ‚น27.7333.33%
2006-โ‚น20.80-4%
2005-โ‚น21.66-3.85%
2004-โ‚น22.53-13.33%
2003-โ‚น25.9983.59%
2002-โ‚น14.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น16.46-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น470.43 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น443.63 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.16 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น275.56 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,220 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA